Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression

Int J Neuropsychopharmacol. 2012 Apr;15(3):375-87. doi: 10.1017/S1461145711000678. Epub 2011 May 9.

Abstract

Neuropeptide S (NPS) and its receptor (NPSR) have been implicated in the mediation of anxiolytic-like behaviour in rodents. However, little knowledge is available regarding the NPS system in depression-related behaviours, and whether NPS also exerts anxiolytic effects in an animal model of psychopathology. Therefore, the aim of this work was to characterize the effects of NPS on depression- and anxiety-related parameters, using male and female rats in a well-validated animal model of depression: the Flinders Sensitive Line (FSL), their controls, the Flinders Resistant Line (FRL), and Sprague-Dawley (SD) rats. We found that FSL showed greater immobility in the forced swim test (FST) than FRL, confirming their phenotype. However, NPS did not affect depression-related behaviour in any rat line. No significant differences in baseline anxiety levels between the FSL and FRL strains were observed, but FSL and FRL rats displayed less anxiety-like behaviour compared to SD rats. NPS decreased anxiety-like behaviour on the elevated plus-maze in all strains. The expression of the NPSR in the amygdala, periventricular hypothalamic nucleus, and hippocampus was equal in all male strains, although a trend towards reduced expression within the amygdala was observed in FSL rats compared to SD rats. In conclusion, NPS had a marked anxiolytic effect in FSL, FRL and SD rats, but did not modify the depression-related behaviour in any strain, in spite of the significant differences in innate level between the strains. These findings suggest that NPS specifically modifies anxiety behaviour but cannot overcome/reverse a genetically mediated depression phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents / administration & dosage*
  • Anxiety Disorders / drug therapy*
  • Anxiety Disorders / physiopathology*
  • Brain / drug effects
  • Brain / physiopathology
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / physiopathology*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Exploratory Behavior / drug effects
  • Exploratory Behavior / physiology
  • Female
  • Genetic Predisposition to Disease
  • Male
  • Maze Learning / drug effects
  • Maze Learning / physiology
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Neuropeptides / administration & dosage*
  • Neuropsychological Tests
  • Rats, Inbred Strains
  • Rats, Sprague-Dawley
  • Receptors, Neuropeptide / metabolism
  • Sex Characteristics
  • Species Specificity
  • Swimming / physiology

Substances

  • Anti-Anxiety Agents
  • Neuropeptides
  • Receptors, Neuropeptide
  • neuropeptide S receptor, rat
  • neuropeptide S, rat